Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15695782rdf:typepubmed:Citationlld:pubmed
pubmed-article:15695782lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15695782lifeskim:mentionsumls-concept:C0031268lld:lifeskim
pubmed-article:15695782lifeskim:mentionsumls-concept:C0228174lld:lifeskim
pubmed-article:15695782lifeskim:mentionsumls-concept:C0034830lld:lifeskim
pubmed-article:15695782lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:15695782lifeskim:mentionsumls-concept:C1708481lld:lifeskim
pubmed-article:15695782pubmed:issue2lld:pubmed
pubmed-article:15695782pubmed:dateCreated2005-2-7lld:pubmed
pubmed-article:15695782pubmed:abstractText2-(18)F-fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine (2-(18)F-fluoro-A-85380) is a PET radioligand that is specific for nicotinic acetylcholine receptors (nAChRs) and has a high affinity for the alpha(4)beta(2) subtype. The purpose of this study was to evaluate different strategies to quantify 2-(18)F-fluoro-A-85380 binding in healthy nonsmoking human volunteers.lld:pubmed
pubmed-article:15695782pubmed:languageenglld:pubmed
pubmed-article:15695782pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15695782pubmed:citationSubsetIMlld:pubmed
pubmed-article:15695782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15695782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15695782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15695782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15695782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15695782pubmed:statusMEDLINElld:pubmed
pubmed-article:15695782pubmed:monthFeblld:pubmed
pubmed-article:15695782pubmed:issn0161-5505lld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:ValetteHéricHlld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:BottlaenderMi...lld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:CoulonChristi...lld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:OttavianiMich...lld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:SyrotaAndréAlld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:DolléFrédéric...lld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:DeverreJean-R...lld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:GrégoireMarie...lld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:RoumenovDimit...lld:pubmed
pubmed-article:15695782pubmed:authorpubmed-author:GallezotJean-...lld:pubmed
pubmed-article:15695782pubmed:issnTypePrintlld:pubmed
pubmed-article:15695782pubmed:volume46lld:pubmed
pubmed-article:15695782pubmed:ownerNLMlld:pubmed
pubmed-article:15695782pubmed:authorsCompleteYlld:pubmed
pubmed-article:15695782pubmed:pagination240-7lld:pubmed
pubmed-article:15695782pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:meshHeadingpubmed-meshheading:15695782...lld:pubmed
pubmed-article:15695782pubmed:year2005lld:pubmed
pubmed-article:15695782pubmed:articleTitleIn vivo imaging of human cerebral nicotinic acetylcholine receptors with 2-18F-fluoro-A-85380 and PET.lld:pubmed
pubmed-article:15695782pubmed:affiliationService Hospitalier Frédéric Joliot, Departement de Recherche Medicale/Direction des Sciences du Vivant, Commissariat à l'Energie Atomique, F-91406 Orsay, France.lld:pubmed
pubmed-article:15695782pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15695782pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:15695782pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15695782pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15695782lld:pubmed